Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease

@article{Kenmotsu2014EffectOP,
  title={Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease},
  author={Hirotsugu Kenmotsu and Tateaki Naito and Keita Mori and Ryo Ko and Akira Ono and Kazushige Wakuda and Hisao Imai and Tetsuhiko Taira and Haruyasu Murakami and Masahiro Endo and Toshiaki Takahashi},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2014},
  volume={75},
  pages={521-526}
}
The prognosis of non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) is unclear. To assess the prognosis of NSCLC patients with ILD treated with platinum-based chemotherapy, we retrospectively analyzed the clinical course of those with ILD. One hundred and four NSCLC patients with ILD treated with platinum-based chemotherapy at Shizuoka Cancer Center between August 2002 and June 2013 were retrospectively reviewed. The combination of carboplatin with paclitaxel was… CONTINUE READING